Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study.

Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study. Am J Geriatr Psychiatry. 2022 01; 30(1):15-28.

View in: PubMed

subject areas

Aged
Depressive Disorder, Major
Electroconvulsive Therapy
Humans
Lithium
Middle Aged
Treatment Outcome
Venlafaxine Hydrochloride

authors with profiles

Rebecca G. Knapp
Martina Mueller
Abeba A Teklehaimanot
Charles H. Kellner